Low-cost steroid could reduce COVID-19 death rate

A study involving thousands of COVID-19 patients in Britain suggests that a low-cost steroid drug known as dexamethasone could significantly reduce the death rate for those sick enough to require respiratory support.

Get the news brief on GeekWire.

By Alan Boyle

Mastermind of Cosmic Log, contributor to GeekWire and Universe Today, author of "The Case for Pluto: How a Little Planet Made a Big Difference," past president of the Council for the Advancement of Science Writing.

Leave a Reply